Given the clear awareness that COVID-19 has not disappeared but is here to stay, fast, high-throughput and relatively low-cost diagnostic techniques are likely to drive the market in the foreseeable future. The results of our clinical evaluation of the Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay during the time of circulating highly mutated SARS-CoV-2 variants such as BA.2.86 and JN.1 confirms the good performance of this technique in the diagnosis of acute SARS-CoV-2 infection, with cumulative accuracy and diagnostic sensitivity at the manufacturer’s cut-off value being 77 % and 72 %, respectively, which is in line with values reported in a previous meta-analysis when earlier SARS-CoV-2 variants were actively circulating. The accuracy and sensitivity in samples from patients with high viral load, who are thought to be the main carriers of SARS-CoV-2 transmission, was even better, showing a near perfect agreement with the molecular biology reference technique and a sensitivity of 95.6 %, which would allow fast, efficient and relatively inexpensive identification of super-spreaders.

Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay

Pighi, Laura;Salvagno, Gian Luca;Lippi, Giuseppe
In corso di stampa

Abstract

Given the clear awareness that COVID-19 has not disappeared but is here to stay, fast, high-throughput and relatively low-cost diagnostic techniques are likely to drive the market in the foreseeable future. The results of our clinical evaluation of the Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay during the time of circulating highly mutated SARS-CoV-2 variants such as BA.2.86 and JN.1 confirms the good performance of this technique in the diagnosis of acute SARS-CoV-2 infection, with cumulative accuracy and diagnostic sensitivity at the manufacturer’s cut-off value being 77 % and 72 %, respectively, which is in line with values reported in a previous meta-analysis when earlier SARS-CoV-2 variants were actively circulating. The accuracy and sensitivity in samples from patients with high viral load, who are thought to be the main carriers of SARS-CoV-2 transmission, was even better, showing a near perfect agreement with the molecular biology reference technique and a sensitivity of 95.6 %, which would allow fast, efficient and relatively inexpensive identification of super-spreaders.
In corso di stampa
COVID-19, SARS-CoV-2, diagnosis, immunoassay, laboratory medicine
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1117507
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact